Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks96ES.L Regulatory News (96ES)

  • There is currently no data for 96ES

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of meetings of certain Covered Bondholders

9 Nov 2015 16:50

RNS Number : 0873F
Barclays Bank PLC
09 November 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT (SEE "SOLICITATION AND DISTRUBUTION RESTRICTIONS" BELOW)

 

BARCLAYS BANK PLC

announces results of meetings of holders of

certain Covered Bonds

9 November 2015. On 16 October 2015, Barclays Bank PLC (the "Issuer") announced invitations to holders of its outstanding covered bonds ("Covered Bondholders") described in the table below (together the "Covered Bonds", and each series of the Covered Bonds a "Series") to consent to the documents relating to the relevant Covered Bonds (each such invitation a "Consent Solicitation"). Separate meetings of the Covered Bondholders of each Series (each a "Meeting") were held earlier today in connection with the Consent Solicitations, and the Issuer now announces the results of each Meeting.

The full terms and conditions of the Consent Solicitations were contained in the consent solicitation memorandum dated 16 October 2015 (the "Consent Solicitation Memorandum") prepared by the Issuer. Capitalised terms used in this announcement but not defined have the meanings given to them in the Consent Solicitation Memorandum.

Details of the Covered Bonds

 

ISIN / Common Code

Outstanding principal amount

EUR 2,000,000,000 Series 2009-1 4.00 per cent. Covered Bonds due 2019 (the "Series 2009-1 Covered Bonds")

XS0456178580 / 045617858

EUR 1,996,700,0001

EUR 1,300,000,000 Series 2010-2 4.25 per cent. Covered Bonds due 2022 (the "Series 2010-2 Covered Bonds")

XS0491009659 / 049100965

EUR 1,273,500,0002

EUR 1,000,000,000 Series 2011-1 4.00 per cent. Covered Bonds due 2021 (the "Series 2011-1 Covered Bonds")

XS0576797947 / 057679794

EUR 1,000,000,000

EUR 1,500,000,000 Series 2011-2 3.625 per cent. Covered Bonds due 2016 (the "Series 2011-2 Covered Bonds")

XS0616754007 / 061675400

EUR 1,500,000,000

____________________________________________

1. This figure excludes the EUR 3,300,000 of the Series 2009-1 Covered Bonds held by the Issuer as at the date of this announcement. The Issuer did not attend and vote at the relevant Meeting in respect of such Series 2009-1 Covered Bonds.

2. This figure excludes the EUR 26,500,000 of the Series 2010-2 Covered Bonds held by the Issuer as at the date of this announcement. The Issuer did not attend and vote at the relevant Meeting in respect of such Series 2010-2 Covered Bonds.

Meetings of Covered Bondholders

The Meetings were held earlier today, and NOTICE IS HEREBY GIVEN to Covered Bondholders that:

(a) at the Meeting in respect of the Series 2009-1 Covered Bonds, the necessary quorum was achieved (with 82.17 per cent. of the aggregate Principal Amount Outstanding of the outstanding Series 2009-1 Covered Bonds being represented at the Meeting) and the relevant Extraordinary Resolution was duly passed (with 92.87 per cent. of votes being cast in favour of the relevant Extraordinary Resolution);

(b) at the Meeting in respect of the Series 2010-2 Covered Bonds, the necessary quorum was achieved (with 80.11 per cent. of the aggregate Principal Amount Outstanding of the outstanding Series 2010-2 Covered Bonds being represented at the Meeting) and the relevant Extraordinary Resolution was duly passed (with 93.11 per cent. of votes being cast in favour of the relevant Extraordinary Resolution);

(c) at the Meeting in respect of the Series 2011-1 Covered Bonds, the necessary quorum was achieved (with 91.24 per cent. of the aggregate Principal Amount Outstanding of the outstanding Series 2011-1 Covered Bonds being represented at the Meeting) and the relevant Extraordinary Resolution was duly passed (with 97.92 per cent. of votes being cast in favour of the relevant Extraordinary Resolution);

(d) at the Meeting in respect of the Series 2011-2 Covered Bonds, the necessary quorum was achieved (with 75.86 per cent. of the aggregate Principal Amount Outstanding of the outstanding Series 2011-2 Covered Bonds being represented at the Meeting) and the relevant Extraordinary Resolution was duly passed (with 92.46 per cent. of votes being cast in favour of the relevant Extraordinary Resolution); and

(e) accordingly, the Amended and Restated Final Terms, the Supplemental Trust Deed and the Amended and Restated Swap Confirmation relating to each of the Series 2009-1 Covered Bonds, the Series 2010-2 Covered Bonds, the Series 2011-1 Covered Bonds and the Series 2011-2 Covered Bonds have been executed by the parties thereto and the amendments to the Conditions of each such Series and the consequential modification of the Swap Agreement relating to each such Series have become effective.

Summary of Modifications to Conditions

The modification of the terms and conditions of each of the Series 2009-1 Covered Bonds, the Series 2010-2 Covered Bonds, the Series 2011-1 Covered Bonds and the Series 2011-2 Covered Bonds as approved in the Meetings for each such Series referred to above provides that, instead of being "hard bullet" Covered Bonds, such Covered Bonds will become "soft bullet" Covered Bonds with (i) an extended due for payment date being the date falling twelve (12) calendar months after the final maturity date of such Covered Bonds and (ii) interest payable in respect of the Series 2009-1 Covered Bonds, the Series 2010-2 Covered Bonds, the Series 2011-1 Covered Bonds and the Series 2011-2 Covered Bonds from (and including) the final maturity date in respect of such Covered Bonds to (but excluding) the extended due for payment date (or, if earlier, the date on which the relevant Series is redeemed in full) payable monthly in arrears and determined by reference to the sum of one-month EURIBOR and a margin, all as further specified in the applicable Amended and Restated Final Terms for such Covered Bonds.

Payment Date

 

Only Covered Bondholders from whom a valid Consent Instruction in favour of the relevant Extraordinary Resolution was received by the Tabulation Agent prior to the Early Instruction Deadline and which was not subsequently revoked are eligible to receive the Early Participation Fee.

The Payment Date for the Consent Solicitations in respect of the Series 2009-1 Covered Bonds, the Series 2010-2 Covered Bonds, the Series 2011-1 Covered Bonds and the Series 2011-2 Covered Bonds will be 12 November 2015, and payment of the Early Participation Fee will be made to relevant holders of such Covered Bonds on such date.

The above times and dates are subject to the right of the Issuer (subject to applicable law and the provisions of the trust deed constituting the Covered Bonds, and as provided in the Consent Solicitation Memorandum) to extend, waive any condition of, amend and/or terminate any Consent Solicitation (other than the terms of the relevant Extraordinary Resolution) as described in the Consent Solicitation Memorandum, and are based on the passing of each Extraordinary Resolution at the first Meeting for the relevant Series.

Covered Bondholders are advised to check with any bank, securities broker or other intermediary through which they hold their Covered Bonds when such intermediary would need to receive instructions from a Covered Bondholder in order for such Covered Bondholder to participate in, or (in the limited circumstances in which revocation is permitted) to validly revoke their instruction to participate in, the relevant Consent Solicitation(s) and/or the relevant Meeting(s) by the deadlines specified above. The deadlines set by any such intermediary and each Clearing System for the submission and (where permitted) revocation of Consent Instructions may be earlier than the relevant deadlines set out above.

Covered Bondholders are advised to read carefully the Consent Solicitation Memorandum for full details of, and information on the procedures for participating in, any Consent Solicitation.

Barclays Bank PLC, acting through its investment bank, is acting as the Solicitation Agent and Lucid Issuer Services Limited is acting as the Tabulation Agent.

Questions and requests for assistance in connection with the Consent Solicitations may be directed to the Solicitation Agent:

SOLICITATION AGENT

Barclays Bank PLC

5 The North Colonnade

Canary Wharf

London E14 4BB

United Kingdom

Telephone: +44 203 134 8515

Attention: Liability Management Group

Email: eu.lm@barclays.com

Questions and requests for assistance in connection with the delivery of Consent Instructions may be directed to the Tabulation Agent:

TABULATION AGENT

Lucid Issuer Services Limited

Leroy House

436 Essex Road

London N1 3QP

United Kingdom

Telephone: +44 20 7704 0880

Attention: Victor Parzyjagla/Thomas Choquet

Email: barclays@lucid-is.com

DISCLAIMER This announcement must be read in conjunction with the Consent Solicitation Memorandum. The Consent Solicitation Memorandum contains important information which should be read carefully before any decision is made with respect to any Consent Solicitation. If any Covered Bondholder is in any doubt as to the action it should take, it is recommended to seek its own financial advice, including in respect of any tax consequences, from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser. Any individual or company whose Covered Bonds are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee must contact such entity if it wishes to participate in the relevant Consent Solicitation or otherwise participate at the relevant Meeting. None of the Issuer, Barclays Covered Bonds LLP (the "LLP"), the Solicitation Agent, the Tabulation Agent and Citicorp Trustee Company Limited (the "Trustee") expresses any opinion about the terms of any Consent Solicitation or Extraordinary Resolution or makes any recommendation whether Covered Bondholders should participate in the relevant Consent Solicitation(s) or otherwise participate at the Meeting(s) applicable to them.

SOLICITATION AND DISTRIBUTION RESTRICTIONS

Neither this announcement nor the Consent Solicitation Memorandum constitutes an invitation to participate in any Consent Solicitation in any jurisdiction in which, or to any person to whom, it is unlawful to make such invitation or for there to be such participation under applicable securities laws. The distribution of this announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law.

Persons into whose possession this announcement and/or the Consent Solicitation Memorandum comes are required by each of the Issuer, the LLP, the Solicitation Agent and the Tabulation Agent to inform themselves about, and to observe, any such restrictions.

Nothing in this announcement or the Consent Solicitation Memorandum constitutes or contemplates an offer of, an offer to purchase or the solicitation of an offer to sell any security in any jurisdiction and participation in any Consent Solicitation by a Covered Bondholder in any circumstances in which such participation is unlawful will not be accepted.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMMGMKLFGKZM
Date   Source Headline
30th Mar 20217:00 amRNSResults of placing in Gamma Communications
29th Mar 20214:47 pmRNSProposed placing in Gamma Communications
16th Mar 20217:00 amRNSResults of placing in Wizz Air
15th Mar 20214:44 pmRNSProposed placing in Wizz Air
9th Mar 20215:25 pmRNSFCA Combined Supplement 2 of 2020
18th Feb 20216:25 pmRNSAnnual Report on Form 20-F
18th Feb 202110:47 amRNSFCA Supplement 1_2020 Barclays Bank Ireland BP16
18th Feb 202110:46 amRNSFCA Supplement 2_2020_Barclays Bank Ireland BP9
18th Feb 202110:39 amRNSFCA Combined Supplement 1_2020 - RNS Announcement
18th Feb 20217:00 amRNSAnnual Financial Report
17th Feb 20217:00 amRNSResults of placing in Hargreaves Lansdown
16th Feb 20214:41 pmRNSProposed placing in Hargreaves Lansdown
29th Jan 20213:16 pmRNSPublication of Suppl.Prospcts
15th Jan 20214:42 pmRNSNotice to Holders of Results of Adjourned Meeting
7th Jan 20213:45 pmRNSFinal Result of Tender Offer to Noteholders
21st Dec 20203:45 pmRNSResult of Tender Offer to Noteholders
16th Dec 20206:27 pmRNSNotice to Security Holders of Results of Meetings
16th Dec 20206:27 pmRNSNotice of Security Holders Adjourned Meetings
16th Dec 20206:26 pmRNSNotice to Security Holders of Results of Meetings
9th Dec 20203:31 pmRNSPublication of a Prospectus
7th Dec 20205:52 pmRNSTender Offer to Noteholders
24th Nov 20201:45 pmRNSAmendment - Notice to holders of Securities
23rd Nov 20207:37 amRNSNotice to holders of outstanding Securities
5th Oct 202010:28 amRNSPost Stab- Commerzbank AT1 No Stabilisation Notice
1st Oct 20207:00 amRNSDirectorate Change
15th Sep 20207:00 amRNSResults of placing in Watches of Switzerland Group
14th Sep 20204:50 pmRNSProposed placing in Watches of Switzerland Group
8th Sep 20208:23 amRNSPre-Stabilisation Notice - Commerzbank AT1
28th Aug 20207:00 amRNSNotice of Redemption
26th Aug 20205:24 pmRNSPublication of BP2 pursuant to the GSSP
12th Aug 202011:36 amRNSArticle 8
12th Aug 202011:10 amRNSArticle 8
7th Aug 202010:50 amRNSPublication of Suppl.Prospcts
29th Jul 20207:00 amRNSHalf-year Report
17th Jul 20202:59 pmRNSPost Stabilisation Notice Exxon - no stabilisation
17th Jul 202011:32 amRNSAnnouncement of Partial Redemption
30th Jun 20202:20 pmRNSPublication of 2020 GSSP Base Prospectus 16
26th Jun 20202:23 pmRNSArticle 8
23rd Jun 20203:06 pmRNSExxon Pre-Stabilisation Notice
22nd Jun 202010:22 amRNSArticle 8
19th Jun 20204:51 pmRNSArticle 8
12th Jun 202012:56 pmRNSBarclays PLC Post Stabilisation Notice
20th May 20205:11 pmRNSArticle 8
15th May 20204:51 pmRNSPublication of Suppl.Prospcts
15th May 20202:32 pmRNSBarclays PLC T2 Pre-Stabilisation Notice
14th May 20203:22 pmRNSArticle 8
12th May 202011:00 amRNSDoc re. rights attached to debt securities
4th May 20204:45 pmRNSPublication of a Prospectus
6th Apr 20205:18 pmRNSDelisting Notice
31st Mar 20201:05 pmRNSNotice to Noteholders Series 11492 Class MV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.